FDA Inspection 1094254 — Taizhou Taifa Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Taizhou Taifa Pharmaceuticals Co., Ltd. on May 15, 2019 in Xianju, Taizhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju, Taizhou (China)